Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for CTVA and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CTVA and 80,000+ other tickers.
See exactly how CTVA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CTVA and 80,000+ other tickers.
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers…
Amova Asset Management Americas Inc. reduced its holdings in shares of Corteva, Inc. (NYSE: CTVA) by 6.2% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 274,132 shares of the company's stock after selling 18,258 shares during the quarter. Amova Asset
The partnership will help farmers in Europe improve nutrient use efficiency The partnership will help farmers in Europe improve nutrient use efficiency
Karen Grimes to be Chair; separation on track for 4Q 2026 INDIANAPOLIS, June 29, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today the board of directors for Vylor Inc., the future publicly traded, advanced seed and genetics company that will result from the current company's planned separation. Karen Grimes will lead the board as Independent Chair.
Greg Page to be Chair; separation on track for 4Q 2026 INDIANAPOLIS, June 29, 2026 /PRNewswire/ -- Corteva Inc. (NYSE: CTVA) announced today its intended board of directors as a standalone publicly-traded, differentiated crop protection company upon its planned separation in the fourth quarter of 2026. Greg Page will lead the nine-person board as Independent Chair as previously announced.
BG, DE and NTR are tapping AgTech and food innovation trends through smarter farming, crop nutrition and sustainable food solutions.